Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouse Embryonic Stem Cells | 3 | 2019 | 36 | 1.430 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2019 | 63 | 1.240 |
Why?
|
| Metal Nanoparticles | 2 | 2019 | 41 | 0.780 |
Why?
|
| Pluripotent Stem Cells | 2 | 2019 | 75 | 0.780 |
Why?
|
| Entrepreneurship | 2 | 2011 | 6 | 0.730 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2019 | 18 | 0.670 |
Why?
|
| RNA Probes | 1 | 2019 | 30 | 0.660 |
Why?
|
| Rhodamines | 1 | 2019 | 22 | 0.660 |
Why?
|
| Quantum Dots | 1 | 2019 | 12 | 0.650 |
Why?
|
| Blastocyst | 2 | 2018 | 76 | 0.650 |
Why?
|
| Electrochemical Techniques | 1 | 2019 | 6 | 0.650 |
Why?
|
| Tungsten | 1 | 2019 | 6 | 0.640 |
Why?
|
| Oxides | 1 | 2019 | 15 | 0.640 |
Why?
|
| Graphite | 1 | 2019 | 9 | 0.640 |
Why?
|
| Metal-Organic Frameworks | 1 | 2018 | 2 | 0.640 |
Why?
|
| Hemin | 1 | 2018 | 17 | 0.630 |
Why?
|
| Peroxidases | 1 | 2018 | 26 | 0.630 |
Why?
|
| Peroxidase | 1 | 2019 | 62 | 0.630 |
Why?
|
| Nickel | 1 | 2018 | 22 | 0.620 |
Why?
|
| Copper | 1 | 2019 | 61 | 0.620 |
Why?
|
| Dendrimers | 1 | 2018 | 5 | 0.620 |
Why?
|
| S Phase | 1 | 2018 | 73 | 0.620 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 63 | 0.610 |
Why?
|
| Mucin-1 | 1 | 2018 | 34 | 0.610 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 28 | 0.600 |
Why?
|
| Immunoassay | 1 | 2018 | 125 | 0.580 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 993 | 0.560 |
Why?
|
| Antibodies | 1 | 2018 | 371 | 0.540 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 351 | 0.530 |
Why?
|
| Nanoparticles | 1 | 2019 | 224 | 0.530 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1440 | 0.490 |
Why?
|
| Neoplasms | 2 | 2019 | 2759 | 0.450 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1915 | 0.420 |
Why?
|
| MicroRNAs | 1 | 2019 | 827 | 0.400 |
Why?
|
| Medical Laboratory Science | 1 | 2011 | 13 | 0.380 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2053 | 0.370 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 97 | 0.350 |
Why?
|
| Capital Financing | 1 | 2010 | 7 | 0.350 |
Why?
|
| Biomedical Technology | 1 | 2010 | 35 | 0.340 |
Why?
|
| Nanocomposites | 2 | 2019 | 3 | 0.320 |
Why?
|
| Gold | 2 | 2019 | 48 | 0.310 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 260 | 0.310 |
Why?
|
| Carbon | 2 | 2019 | 92 | 0.300 |
Why?
|
| Cell Survival | 3 | 2019 | 805 | 0.300 |
Why?
|
| Health Personnel | 1 | 2011 | 493 | 0.270 |
Why?
|
| HEK293 Cells | 2 | 2019 | 738 | 0.260 |
Why?
|
| Risk Management | 1 | 2006 | 69 | 0.260 |
Why?
|
| Medical Errors | 1 | 2006 | 155 | 0.230 |
Why?
|
| Microfluidics | 1 | 2024 | 18 | 0.220 |
Why?
|
| Hematology | 1 | 2024 | 38 | 0.220 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 216 | 0.220 |
Why?
|
| Physicians | 1 | 2010 | 581 | 0.220 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 208 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2022 | 54 | 0.200 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3286 | 0.200 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 644 | 0.180 |
Why?
|
| Investments | 2 | 2011 | 12 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 382 | 0.170 |
Why?
|
| Limit of Detection | 1 | 2019 | 60 | 0.160 |
Why?
|
| Mesoderm | 1 | 2019 | 111 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 125 | 0.160 |
Why?
|
| Benzidines | 1 | 2018 | 2 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 49 | 0.160 |
Why?
|
| X-Ray Diffraction | 1 | 2019 | 95 | 0.160 |
Why?
|
| Colorimetry | 1 | 2018 | 15 | 0.160 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 11 | 0.160 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2019 | 396 | 0.150 |
Why?
|
| Catalysis | 1 | 2018 | 125 | 0.150 |
Why?
|
| Luminescence | 1 | 2018 | 15 | 0.150 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2018 | 59 | 0.150 |
Why?
|
| Coloring Agents | 1 | 2018 | 77 | 0.150 |
Why?
|
| Hydrogen Peroxide | 1 | 2018 | 113 | 0.150 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 221 | 0.150 |
Why?
|
| Cigarette Smoking | 1 | 2018 | 58 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2022 | 884 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 444 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 1871 | 0.140 |
Why?
|
| Kinetics | 1 | 2019 | 1317 | 0.140 |
Why?
|
| Apoptosis | 2 | 2023 | 1787 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1063 | 0.130 |
Why?
|
| Mice | 4 | 2022 | 17557 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 1525 | 0.110 |
Why?
|
| Humans | 10 | 2025 | 123288 | 0.110 |
Why?
|
| Cell Line | 1 | 2018 | 2771 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2478 | 0.100 |
Why?
|
| Intellectual Property | 1 | 2011 | 8 | 0.100 |
Why?
|
| Marketing | 1 | 2011 | 8 | 0.100 |
Why?
|
| Animals | 4 | 2022 | 33853 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2297 | 0.090 |
Why?
|
| Forecasting | 1 | 2011 | 354 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2010 | 63 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1664 | 0.080 |
Why?
|
| Time Factors | 1 | 2019 | 6223 | 0.080 |
Why?
|
| Employee Discipline | 1 | 2006 | 5 | 0.070 |
Why?
|
| New Zealand | 1 | 2006 | 50 | 0.070 |
Why?
|
| Public Opinion | 1 | 2006 | 56 | 0.060 |
Why?
|
| Neoplasm Grading | 1 | 2025 | 266 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2024 | 69 | 0.060 |
Why?
|
| Emotions | 1 | 2006 | 362 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2024 | 247 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 427 | 0.050 |
Why?
|
| Leukocytes | 1 | 2024 | 206 | 0.050 |
Why?
|
| Feeder Cells | 1 | 2022 | 9 | 0.050 |
Why?
|
| Genetic Background | 1 | 2022 | 7 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 654 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 791 | 0.050 |
Why?
|
| Proteins | 1 | 2025 | 1040 | 0.040 |
Why?
|
| Female | 3 | 2025 | 65630 | 0.040 |
Why?
|
| Smoke | 1 | 2018 | 49 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 3385 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2022 | 3045 | 0.030 |
Why?
|
| United States | 1 | 2011 | 10657 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 29093 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4361 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2530 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 19180 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7129 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 26095 | 0.020 |
Why?
|
| Male | 1 | 2023 | 60346 | 0.010 |
Why?
|